Global Type 1 Diabetes Market Research Report 2024

Report ID: 1991692 | Published Date: Oct 2024 | No. of Page: 93 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Type 1 Diabetes Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Rapid Acting Insulin Analogs
        1.2.3 Long Acting Insulin Analogs
        1.2.4 Premix Insulin Analogs
    1.3 Market by Application
        1.3.1 Global Type 1 Diabetes Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostic clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Type 1 Diabetes Market Perspective (2017-2028)
    2.2 Type 1 Diabetes Growth Trends by Region
        2.2.1 Type 1 Diabetes Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Type 1 Diabetes Historic Market Size by Region (2017-2022)
        2.2.3 Type 1 Diabetes Forecasted Market Size by Region (2023-2028)
    2.3 Type 1 Diabetes Market Dynamics
        2.3.1 Type 1 Diabetes Industry Trends
        2.3.2 Type 1 Diabetes Market Drivers
        2.3.3 Type 1 Diabetes Market Challenges
        2.3.4 Type 1 Diabetes Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Type 1 Diabetes Players by Revenue
        3.1.1 Global Top Type 1 Diabetes Players by Revenue (2017-2022)
        3.1.2 Global Type 1 Diabetes Revenue Market Share by Players (2017-2022)
    3.2 Global Type 1 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Type 1 Diabetes Revenue
    3.4 Global Type 1 Diabetes Market Concentration Ratio
        3.4.1 Global Type 1 Diabetes Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Type 1 Diabetes Revenue in 2021
    3.5 Type 1 Diabetes Key Players Head office and Area Served
    3.6 Key Players Type 1 Diabetes Product Solution and Service
    3.7 Date of Enter into Type 1 Diabetes Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Type 1 Diabetes Breakdown Data by Type
    4.1 Global Type 1 Diabetes Historic Market Size by Type (2017-2022)
    4.2 Global Type 1 Diabetes Forecasted Market Size by Type (2023-2028)
5 Type 1 Diabetes Breakdown Data by Application
    5.1 Global Type 1 Diabetes Historic Market Size by Application (2017-2022)
    5.2 Global Type 1 Diabetes Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Type 1 Diabetes Market Size (2017-2028)
    6.2 North America Type 1 Diabetes Market Size by Country (2017-2022)
    6.3 North America Type 1 Diabetes Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Type 1 Diabetes Market Size (2017-2028)
    7.2 Europe Type 1 Diabetes Market Size by Country (2017-2022)
    7.3 Europe Type 1 Diabetes Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Type 1 Diabetes Market Size (2017-2028)
    8.2 Asia-Pacific Type 1 Diabetes Market Size by Country (2017-2022)
    8.3 Asia-Pacific Type 1 Diabetes Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Type 1 Diabetes Market Size (2017-2028)
    9.2 Latin America Type 1 Diabetes Market Size by Country (2017-2022)
    9.3 Latin America Type 1 Diabetes Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Type 1 Diabetes Market Size (2017-2028)
    10.2 Middle East & Africa Type 1 Diabetes Market Size by Country (2017-2022)
    10.3 Middle East & Africa Type 1 Diabetes Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Type 1 Diabetes Introduction
        11.1.4 Abbott Revenue in Type 1 Diabetes Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Detail
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Type 1 Diabetes Introduction
        11.2.4 Bayer Revenue in Type 1 Diabetes Business (2017-2022)
        11.2.5 Bayer Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Detail
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Type 1 Diabetes Introduction
        11.3.4 Eli Lilly Revenue in Type 1 Diabetes Business (2017-2022)
        11.3.5 Eli Lilly Recent Development
    11.4 BD
        11.4.1 BD Company Detail
        11.4.2 BD Business Overview
        11.4.3 BD Type 1 Diabetes Introduction
        11.4.4 BD Revenue in Type 1 Diabetes Business (2017-2022)
        11.4.5 BD Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Detail
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Type 1 Diabetes Introduction
        11.5.4 Johnson & Johnson Revenue in Type 1 Diabetes Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Development
    11.6 Merck
        11.6.1 Merck Company Detail
        11.6.2 Merck Business Overview
        11.6.3 Merck Type 1 Diabetes Introduction
        11.6.4 Merck Revenue in Type 1 Diabetes Business (2017-2022)
        11.6.5 Merck Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Detail
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Type 1 Diabetes Introduction
        11.7.4 Pfizer Revenue in Type 1 Diabetes Business (2017-2022)
        11.7.5 Pfizer Recent Development
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Detail
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Type 1 Diabetes Introduction
        11.8.4 AstraZeneca Revenue in Type 1 Diabetes Business (2017-2022)
        11.8.5 AstraZeneca Recent Development
    11.9 Roche
        11.9.1 Roche Company Detail
        11.9.2 Roche Business Overview
        11.9.3 Roche Type 1 Diabetes Introduction
        11.9.4 Roche Revenue in Type 1 Diabetes Business (2017-2022)
        11.9.5 Roche Recent Development
    11.10 Smiths Medical
        11.10.1 Smiths Medical Company Detail
        11.10.2 Smiths Medical Business Overview
        11.10.3 Smiths Medical Type 1 Diabetes Introduction
        11.10.4 Smiths Medical Revenue in Type 1 Diabetes Business (2017-2022)
        11.10.5 Smiths Medical Recent Development
    11.11 Medtronic
        11.11.1 Medtronic Company Detail
        11.11.2 Medtronic Business Overview
        11.11.3 Medtronic Type 1 Diabetes Introduction
        11.11.4 Medtronic Revenue in Type 1 Diabetes Business (2017-2022)
        11.11.5 Medtronic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Type 1 Diabetes Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Rapid Acting Insulin Analogs
    Table 3. Key Players of Long Acting Insulin Analogs
    Table 4. Key Players of Premix Insulin Analogs
    Table 5. Global Type 1 Diabetes Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Type 1 Diabetes Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Type 1 Diabetes Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Type 1 Diabetes Market Share by Region (2017-2022)
    Table 9. Global Type 1 Diabetes Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Type 1 Diabetes Market Share by Region (2023-2028)
    Table 11. Type 1 Diabetes Market Trends
    Table 12. Type 1 Diabetes Market Drivers
    Table 13. Type 1 Diabetes Market Challenges
    Table 14. Type 1 Diabetes Market Restraints
    Table 15. Global Type 1 Diabetes Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Type 1 Diabetes Market Share by Players (2017-2022)
    Table 17. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes as of 2021)
    Table 18. Ranking of Global Top Type 1 Diabetes Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Type 1 Diabetes Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Type 1 Diabetes Product Solution and Service
    Table 22. Date of Enter into Type 1 Diabetes Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Type 1 Diabetes Revenue Market Share by Type (2017-2022)
    Table 26. Global Type 1 Diabetes Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Type 1 Diabetes Revenue Market Share by Type (2023-2028)
    Table 28. Global Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Type 1 Diabetes Revenue Market Share by Application (2017-2022)
    Table 30. Global Type 1 Diabetes Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Type 1 Diabetes Revenue Market Share by Application (2023-2028)
    Table 32. North America Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Type 1 Diabetes Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Type 1 Diabetes Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Abbott Company Detail
    Table 43. Abbott Business Overview
    Table 44. Abbott Type 1 Diabetes Product
    Table 45. Abbott Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 46. Abbott Recent Development
    Table 47. Bayer Company Detail
    Table 48. Bayer Business Overview
    Table 49. Bayer Type 1 Diabetes Product
    Table 50. Bayer Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 51. Bayer Recent Development
    Table 52. Eli Lilly Company Detail
    Table 53. Eli Lilly Business Overview
    Table 54. Eli Lilly Type 1 Diabetes Product
    Table 55. Eli Lilly Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 56. Eli Lilly Recent Development
    Table 57. BD Company Detail
    Table 58. BD Business Overview
    Table 59. BD Type 1 Diabetes Product
    Table 60. BD Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 61. BD Recent Development
    Table 62. Johnson & Johnson Company Detail
    Table 63. Johnson & Johnson Business Overview
    Table 64. Johnson & Johnson Type 1 Diabetes Product
    Table 65. Johnson & Johnson Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 66. Johnson & Johnson Recent Development
    Table 67. Merck Company Detail
    Table 68. Merck Business Overview
    Table 69. Merck Type 1 Diabetes Product
    Table 70. Merck Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 71. Merck Recent Development
    Table 72. Pfizer Company Detail
    Table 73. Pfizer Business Overview
    Table 74. Pfizer Type 1 Diabetes Product
    Table 75. Pfizer Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 76. Pfizer Recent Development
    Table 77. AstraZeneca Company Detail
    Table 78. AstraZeneca Business Overview
    Table 79. AstraZeneca Type 1 Diabetes Product
    Table 80. AstraZeneca Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 81. AstraZeneca Recent Development
    Table 82. Roche Company Detail
    Table 83. Roche Business Overview
    Table 84. Roche Type 1 Diabetes Product
    Table 85. Roche Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 86. Roche Recent Development
    Table 87. Smiths Medical Company Detail
    Table 88. Smiths Medical Business Overview
    Table 89. Smiths Medical Type 1 Diabetes Product
    Table 90. Smiths Medical Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 91. Smiths Medical Recent Development
    Table 92. Medtronic Company Detail
    Table 93. Medtronic Business Overview
    Table 94. Medtronic Type 1 DiabetesProduct
    Table 95. Medtronic Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)
    Table 96. Medtronic Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Type 1 Diabetes Market Share by Type: 2021 VS 2028
    Figure 2. Rapid Acting Insulin Analogs Features
    Figure 3. Long Acting Insulin Analogs Features
    Figure 4. Premix Insulin Analogs Features
    Figure 5. Global Type 1 Diabetes Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Diagnostic clinics Case Studies
    Figure 8. Type 1 Diabetes Report Years Considered
    Figure 9. Global Type 1 Diabetes Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Type 1 Diabetes Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Type 1 Diabetes Market Share by Region: 2021 VS 2028
    Figure 12. Global Type 1 Diabetes Market Share by Players in 2021
    Figure 13. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Type 1 Diabetes Revenue in 2021
    Figure 15. North America Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Type 1 Diabetes Market Share by Country (2017-2028)
    Figure 17. United States Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Type 1 Diabetes Market Share by Country (2017-2028)
    Figure 21. Germany Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Type 1 Diabetes Market Share by Region (2017-2028)
    Figure 29. China Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Type 1 Diabetes Market Share by Country (2017-2028)
    Figure 37. Mexico Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Type 1 Diabetes Market Share by Country (2017-2028)
    Figure 41. Turkey Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbott Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 44. Bayer Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 45. Eli Lilly Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 46. BD Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 47. Johnson & Johnson Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 49. Pfizer Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 50. AstraZeneca Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 51. Roche Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 52. Smiths Medical Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 53. Medtronic Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Bayer
Eli Lilly
BD
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Roche
Smiths Medical
Medtronic
Frequently Asked Questions
Type 1 Diabetes report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Type 1 Diabetes report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Type 1 Diabetes report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

UHD Display

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More